Respiratory depression (RD) is a serious side effect of morphine and detrimental to effective analgesia. We reported that variants of the ATP binding cassette gene ABCC3 (facilitates hepatic morphine metabolite efflux) affect morphine metabolite clearance. In this study of 316 children undergoing tonsillectomy, we found significant association between ABCC3 variants and RD leading to prolonged postoperative care unit stay (prolonged RD). Allele A at rs4148412 and allele G at rs729923 caused a 2.36 (95% CI=1.28–4.37, P=0.0061) and 3.7 (95% CI 1.47–9.09, P=0.0050) times increase in odds of prolonged RD, respectively. These clinical associations were supported by increased formation clearance of morphine glucuronides in children with rs4148412 AA and rs4973665 CC genotypes in this cohort, as well as an independent spine surgical cohort of 67 adolescents. This is the first study to report association of ABCC3 variants with opioid-related RD, and morphine metabolite formation (in two independent surgical cohorts).
Subscribe to Journal
Get full journal access for 1 year
only $66.50 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Lotsch J, Dudziak R, Freynhagen R, Marschner J, Geisslinger G . Fatal respiratory depression after multiple intravenous morphine injections. Clin Pharmacokinet 2006; 45: 1051–1060.
Nelson KL, Yaster M, Kost-Byerly S, Monitto CL . A national survey of American Pediatric Anesthesiologists: patient-controlled analgesia and other intravenous opioid therapies in pediatric acute pain management. Anesth Analg 2010; 110: 754–760.
Fecho K, Lunney AT, Boysen PG, Rock P, Norfleet EA . Postoperative mortality after inpatient surgery: incidence and risk factors. Ther Clin Risk Manag 2008; 4: 681–688.
Fecho K, Jackson F, Smith F, Overdyk FJ . In-hospital resuscitation: opioids and other factors influencing survival. Ther Clin Risk Manag 2009; 5: 961–968.
Angst MS, Lazzeroni LC, Phillips NG, Drover DR, Tingle M, Ray A et al. Aversive and reinforcing opioid effects: a pharmacogenomic twin study. Anesthesiology 2012; 117: 22–37.
Chidambaran V, Mavi J, Esslinger H, Pilipenko V, Martin LJ, Zhang K et al. Association of OPRM1 A118G variant with risk of morphine-induced respiratory depression following spine fusion in adolescents. Pharmacogenomics J 2014; 15: 255–262.
Sadhasivam S, Chidambaran V, Zhang X, Meller J, Esslinger H, Zhang K et al. Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. Pharmacogenomics J 2014; 15: 119–126.
Sadhasivam S, Zhang X, Chidambaran V, Mavi J, Pilipenko V, Mersha TB et al. Novel associations between FAAH genetic variants and postoperative central opioid-related adverse effects. Pharmacogenomics J 2015; 15: 436–442.
Klepstad P, Dale O, Kaasa S, Zahlsen K, Aamo T, Fayers P et al. Influences on serum concentrations of morphine, M6G and M3G during routine clinical drug monitoring: a prospective survey in 300 adult cancer patients. Acta Anaesthesiol Scand 2003; 47: 725–731.
Thorn CF, Klein TE, Altman RB . Codeine and morphine pathway. Pharmacogenet Genomics 2009; 19: 556–558.
Grisk O, Schlueter T, Steinbach A, Ciecholewski S, Kloeting I, Voelker U et al. Effects of generalized and kidney specific Mrp2 (ABCC2) deficiency on renal elimination of PAH and morphine-6-glucuronide. FASEB J 2007; 21: 11.
Huwyler J, Drewe J, Klusemann C, Fricker G . Evidence for P-glycoprotein-modulated penetration of morphine-6-glucuronide into brain capillary endothelium. Br J Pharmacol 1996; 118: 1879–1885.
Kharasch ED, Hoffer C, Whittington D, Sheffels P . Role of P-glycoprotein in the intestinal absorption and clinical effects of morphine. Clin Pharmacol Ther 2003; 74: 543–554.
Lotsch J, Schmidt R, Vetter G, Schmidt H, Niederberger E, Geisslinger G et al. Increased CNS uptake and enhanced antinociception of morphine-6-glucuronide in rats after inhibition of P-glycoprotein. J Neurochem 2002; 83: 241–248.
Tzvetkov MV, dos Santos Pereira JN, Meineke I, Saadatmand AR, Stingl JC, Brockmöller J . Morphine is a substrate of the organic cation transporter OCT1 and polymorphisms in OCT1 gene affect morphine pharmacokinetics after codeine administration. Biochem Pharmacol 2013; 86: 666–678.
van de Wetering K, Zelcer N, Kuil A, Feddema W, Hillebrand M, Vlaming ML et al. Multidrug resistance proteins 2 and 3 provide alternative routes for hepatic excretion of morphine-glucuronides. Mol Pharmacol 2007; 72: 387–394.
Xie R, Hammarlund-Udenaes M, de Boer AG, de Lange EC . The role of P-glycoprotein in blood-brain barrier transport of morphine: transcortical microdialysis studies in mdr1a (-/-) and mdr1a (+/+) mice. Br J Pharmacol 1999; 128: 563–568.
Zelcer N, van de Wetering K, Hillebrand M, Sarton E, Kuil A, Wielinga PR et al. Mice lacking multidrug resistance protein 3 show altered morphine pharmacokinetics and morphine-6-glucuronide antinociception. Proc Natl Acad Sci USA 2005; 102: 7274–7279.
Venkatasubramanian R, Fukuda T, Niu J, Mizuno T, Chidambaran V, Vinks AA et al. ABCC3 and OCT1 genotypes influence pharmacokinetics of morphine in children. Pharmacogenomics 2014; 15: 1297–1309.
Fukuda T, Chidambaran V, Mizuno T, Venkatasubramanian R, Ngamprasertwong P, Olbrecht V et al. OCT1 genetic variants influence the pharmacokinetics of morphine in children. Pharmacogenomics 2013; 14: 1141–1151.
Chervin RD, Hedger K, Dillon JE, Pituch KJ . Pediatric sleep questionnaire (PSQ): validity and reliability of scales for sleep-disordered breathing, snoring, sleepiness, and behavioral problems. Sleep Med 2000; 1: 21–32.
Chervin RD, Weatherly RA, Garetz SL, Ruzicka DL, Giordani BJ, Hodges EK et al. Pediatric sleep questionnaire: prediction of sleep apnea and outcomes. Arch Otolaryngol Head Neck Surg 2007; 133: 216–222.
Boyle AP, Hong EL, Hariharan M, Cheng Y, Schaub MA, Kasowski M et al. Annotation of functional variation in personal genomes using RegulomeDB. Genome Res 2012; 22: 1790–1797.
Clavijo CF, Hoffman KL, Thomas JJ, Carvalho B, Chu LF, Drover DR et al. A sensitive assay for the quantification of morphine and its active metabolites in human plasma and dried blood spots using high-performance liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem 2011; 400: 715–728.
Lindbom L, Pihlgren P, Jonsson EN . PsN-Toolkit-a collection of computer intensive statistical methods for non-linear mixed effect modeling using NON MEM. Comput Methods Programs Biomed 2005; 79: 241–257.
Uchiumi T, Hinoshita E, Haga S, Nakamura T, Tanaka T, Toh S et al. Isolation of a novel human canalicular multispecific organic anion transporter, cMOAT2/MRP3, and its expression in cisplatin-resistant cancer cells with decreased ATP-dependent drug transport. Biochem Biophys Res Commun 1998; 252: 103–110.
Konig J, Rost D, Cui Y, Keppler D . Characterization of the human multidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membrane. Hepatology 1999; 29: 1156–1163.
Borst P, Elferink RO . Mammalian ABC transporters in health and disease. Annu Rev Biochem 2002; 71: 537–592.
Kruh GD, Belinsky MG . The MRP family of drug efflux pumps. Oncogene 2003; 22: 7537–7552.
Zelcer N, van de Wetering K, de Waart R, Scheffer GL, Marschall HU, Wielinga PR et al. Mice lacking Mrp3 (Abcc3) have normal bile salt transport, but altered hepatic transport of endogenous glucuronides. J Hepatol 2006; 44: 768–775.
Milne RW, Jensen RH, Larsen C, Evans AM, Nation RL . Comparison of the disposition of hepatically-generated morphine-3-glucuronide and morphine-6-glucuronide in isolated perfused liver from the guinea pig. Pharm Res 1997; 14: 1014–1018.
McVicker G, van de Geijn B, Degner JF, Cain CE, Banovich NE, Raj A et al. Identification of genetic variants that affect histone modifications in human cells. Science 2013; 342: 747–749.
Schaub MA, Boyle AP, Kundaje A, Batzoglou S, Snyder M . Linking disease associations with regulatory information in the human genome. Genome Res 2012; 22: 1748–1759.
Heintzman ND, Ren B . Finding distal regulatory elements in the human genome. Curr Opin Genet Dev 2009; 19: 541–549.
Visel A, Rubin EM, Pennacchio LA . Genomic views of distant-acting enhancers. Nature 2009; 461: 199–205.
Heintzman ND, Hon GC, Hawkins RD, Kheradpour P, Stark A, Harp LF et al. Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature 2009; 459: 108–112.
Barski A, Cuddapah S, Cui K, Roh TY, Schones DE, Wang Z et al. High-resolution profiling of histone methylations in the human genome. Cell 2007; 129: 823–837.
Creyghton MP, Cheng AW, Welstead GG, Kooistra T, Carey BW, Steine EJ et al. Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc Natl Acad Sci USA 2010; 107: 21931–21936.
Christrup LL . Morphine metabolites. Acta Anaesthesiol Scand 1997; 41: 116–122.
Hasselstrom J, Sawe J . Morphine pharmacokinetics and metabolism in humans. Enterohepatic cycling and relative contribution of metabolites to active opioid concentrations. Clin Pharm 1993; 24: 344–354.
Lang T, Hitzl M, Burk O, Mornhinweg E, Keil A, Kerb R et al. Genetic polymorphisms in the multidrug resistance-associated protein 3 (ABCC3, MRP3) gene and relationship to its mRNA and protein expression in human liver. Pharmacogenetics 2004; 14: 155–164.
Gradhand U, Tegude H, Burk O, Eichelbaum M, Fromm MF, Konig J . Functional analysis of the polymorphism -211C>T in the regulatory region of the human ABCC3 gene. Life Sci 2007; 80: 1490–1494.
Doerfel C, Rump A, Sauerbrey A, Gruhn B, Zintl F, Steinbach D . In acute leukemia, the polymorphism -211C>T in the promoter region of the multidrug resistance-associated protein 3 (MRP3) does not determine the expression level of the gene. Pharmacogenet Genomics 2006; 16: 149–150.
Sawe J, Svensson JO, Rane A . Morphine metabolism in cancer patients on increasing oral doses—no evidence for autoinduction or dose-dependence. Br J Clin Pharmacol 1983; 16: 85–93.
This work was supported in part by USPHS Grant #UL1 RR026314 from the National Center for Research Resources and Electronic Medical Records and Genomics (eMERGE) network U01 grant #U01HG006828, NIH and with the Place Outcomes Research Award (PI: SS) and Translational Research Award (PIs: SS), Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, USA. The study in the spine surgical cohort was supported by Eunice Kennedy Shriver National Institute Of Child Health & Human Development of the National Institutes of Health under award number K23HD082782 (PI: VC), and the Clinical Research Feasibility Funds (PI: VC) via Grant 8 UL1 TR000077 from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. It was also supported by the APSF/ASA Safety Scientist Career Development Award by the Anesthesia Patient Safety Foundation (PI: Chidambaran). Additional research funding support was provided by the Department of Anesthesia, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, USA. No financial support except departmental salary support for the authors. This pharmacogenetic study was designed and undertaken by the authors.
The authors directed and had access to all the analyses and the full clinical and genetic database, wrote all drafts of the report, decided to publish the results and attest for the accuracy and completeness of the data. Specifically, SS, VC and TF conceived of and designed the research. SS, VC, RV, JN and TM acquired the data. SS, VC, RV, AAV, XZ and LJM analyzed and interpreted the data. XZ and JM did localization of SNPs in ABCC3 transporter and proposed mechanistic pathways. XZ and LJM did statistical analyses. VC, RV and SS drafted the initial manuscript. SS participated in funding and supervision. All authors made critical revisions to the report for important intellectual content.
The authors declare no conflict of interest.
Supplementary Information accompanies the paper on the The Pharmacogenomics Journal website
About this article
Cite this article
Chidambaran, V., Venkatasubramanian, R., Zhang, X. et al. ABCC3 genetic variants are associated with postoperative morphine-induced respiratory depression and morphine pharmacokinetics in children. Pharmacogenomics J 17, 162–169 (2017). https://doi.org/10.1038/tpj.2015.98
ABCB1, ABCG2, ABCC1, ABCC2, and ABCC3 drug transporter polymorphisms and their impact on drug bioavailability: what is our current understanding?
Expert Opinion on Drug Metabolism & Toxicology (2021)
Pharmacotherapy of neonatal opioid withdrawal syndrome: a review of pharmacokinetics and pharmacodynamics
Expert Opinion on Drug Metabolism & Toxicology (2021)
Pediatric obstructive sleep apnea revisited: Perioperative considerations for the pediatric Anesthesiologist
International Journal of Pediatric Otorhinolaryngology (2020)
Chemical Reviews (2020)